The optimization of the use of radiation in medicine is articulated in the study of the radiobiological efficacy of radiation beams of clinical interest; in the analysis of the effects of low doses and variable dose rates and of the mitigation of exposure risk; in the identification of metabolic tumor markers to personalize radiation therapies; in the characterization of imaging devices and dose delivery systems for hadrontherapy (accelerators).
The results of the research make it possible to implement quality assurance programs within the National Health Service (NHS) in radiotherapy, radiodiagnostics, interventional radiology, nuclear medicine (radioisotopes and detectors) and teleradiology.
